About
Virica Biotech develops small molecule Viral Sensitizers (VSE™) that transiently suppress host cell defenses to enhance viral vector production yield and quality, targeting manufacturers of cell and gene therapies and vaccines.
Explore Virica Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.